Christopher C. Schreiber serves as Executive at Akers Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Christopher C. Schreiber has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 16, 2021 involved selling 46,113 shares valued at $227.8K.
Christopher C. Schreiber currently holds 88,238 shares of Akers Biosciences, Inc. (AKER), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher C. Schreiber has been a net neutral trader of AKER stock. They have purchased $0 and sold $0 worth of shares.
Christopher C. Schreiber's most recent insider trade was on Apr 16, 2021, when they sold 46,113 shares at $4.94 per share.
Get notified when new Form 4 filings are submitted
| 131,750 |
| $N/A |
| Discretionary |
| Jan 1, 2020 | AKER | $0 | Option Exercise | 5,201 | $N/A | Discretionary |